In stunning, more like earth shattering piece of news Johnson and Johnson (NYSE: JNJ) is shutting down Animas their insulin pump unit and signed an agreement with Medtronic (NYSE: MDT) the insulin pump market leader, to take over their patients. According to a company issued press release this morning;
“Animas Corporation, one of the Johnson & Johnson Diabetes Care Companies, today announced that it intends to discontinue the manufacturing and sale of Animas® Vibe® and OneTouch Ping® insulin pumps, close operations and exit the insulin pump business.
Animas has selected Medtronic plc (NYSE: MDT), a world leader in diabetes, as its . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.